Iohexol Injection Market Outlook 2026-2034: Market Size, Share and Growth Analysis

The Iohexol Injection Market is estimated at US$2 billion in 2026 and is projected to grow at a CAGR of 8.8% to reach US$3.9 billion by 2034.

Market Overview

The Iohexol Injection Market covers injectable iohexol contrast media used to improve visualization in diagnostic imaging procedures.

Concentration, presentation and compatibility with the intended imaging workflow influence procurement; dependable supply matters to scheduled procedures.

Key Companies Analysed

GE HealthCare
Bracco
Bayer
Guerbet
Jiangsu Hengrui
Taizhou Xinyou
Jodas Expoim
Sanochemia
Unijules
Alembic Pharmaceuticals
Tianjin Jinyao
Yangtze River Pharmaceutical
Liaoning Chengda
Mylan
Pfizer
Fresenius Kabi
Sandoz
Accord Healthcare
Dr. Reddy's
Hikma

Geographic Coverage

North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

Updated PDF report and an MS Excel workbook containing market tables and figures.
7-day post-sale analyst support for clarifications and in-scope supplementary data.
Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

1. Contents and Report Guide

1.1. List of Tables
1.2. List of Figures

2. Global Iohexol Injection Market Overview

2.1. Iohexol Injection Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets

3. Iohexol Injection Market Dynamics

3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations

4. Iohexol Injection Market Strategic Analysis

4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment

5. Global Iohexol Injection Market Size, Share and Forecast, 2025-2034

5.1. Revenue Outlook, 2025-2034 (US$ billion)

6. North America Iohexol Injection Market Outlook to 2034

6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico

7. Europe Iohexol Injection Market Outlook to 2034

7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia

8. Asia-Pacific Iohexol Injection Market Outlook to 2034

8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam

9. Middle East and Africa Iohexol Injection Market Outlook to 2034

9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt

10. South and Central America Iohexol Injection Market Outlook to 2034

10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru

11. Iohexol Injection Market Competitive Landscape

11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. GE HealthCare
11.2.2. Bracco
11.2.3. Bayer
11.2.4. Guerbet
11.2.5. Jiangsu Hengrui
11.2.6. Taizhou Xinyou
11.2.7. Jodas Expoim
11.2.8. Sanochemia
11.2.9. Unijules
11.2.10. Alembic Pharmaceuticals
11.2.11. Tianjin Jinyao
11.2.12. Yangtze River Pharmaceutical
11.2.13. Liaoning Chengda
11.2.14. Mylan
11.2.15. Pfizer
11.2.16. Fresenius Kabi
11.2.17. Sandoz
11.2.18. Accord Healthcare
11.2.19. Dr. Reddy's
11.2.20. Hikma

12. Appendix

12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

GE HealthCare
Bracco
Bayer
Guerbet
Jiangsu Hengrui
Taizhou Xinyou
Jodas Expoim
Sanochemia
Unijules
Alembic Pharmaceuticals
Tianjin Jinyao
Yangtze River Pharmaceutical
Liaoning Chengda
Mylan
Pfizer
Fresenius Kabi
Sandoz
Accord Healthcare
Dr. Reddy's
Hikma

Table Information

Report Attribute	Details
No. of Pages	160
Published	October 2026
Forecast Period	2026 - 2034
Estimated Market Value ( USD ) in 2026	$ 2 Billion
Forecasted Market Value ( USD ) by 2034	$ 3.9 Billion
Compound Annual Growth Rate	8.8%
Regions Covered	Global
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a single user license, allowing one user access to the product.	€3084EUR$3,320USD£2,580GBP €3855EUR$4,150USD£3,225GBP
Hard Copy	A printed copy of the product will be shipped to you.		€3381EUR$3,640USD£2,829GBP €4226EUR$4,550USD£3,536GBP
SITE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4570EUR$4,920USD£3,823GBP €5712EUR$6,150USD£4,779GBP
ENTERPRISE LICENSE PDF and Excel	The electronic report will be emailed to you. The file formats are PDF and Excel.	This is an enterprise license, allowing all employees within your organization access to the product.	€6056EUR$6,520USD£5,067GBP €7570EUR$8,150USD£6,333GBP

Market Overview

Key Companies Analysed

Geographic Coverage

Report Delivery and Support

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Iohexol Injection Market - Global Forecast 2026-2032

Iohexol Hydrolysate Market - Global Forecast 2026-2032

Iohexol (CAS 66108-95-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Bacteriostatic Water for Injection Market Outlook 2026-2034: by Packaging Material (Glass, Plastic, Others), Application, Container Type, End User

Propofol Injection Market Outlook 2026-2034: Market Size, Share and Growth Analysis